Journal article
1870-LB: Evaluating Remission of Type 2 Diabetes Using a Metabolic Intervention Including Fixed-Ratio Insulin Degludec and Liraglutide—A Randomized Controlled Trial
Abstract
Introduction & Objective: Remission is an emerging therapeutic target in type 2 diabetes. The aim was to evaluate the effect on type 2 diabetes remission of a short-term intensive metabolic intervention consisting of frequent diet, exercise and diabetes management coaching, together with metformin and fixed-ratio insulin degludec/liraglutide. Methods: In a multicenter open-label randomized controlled trial, insulin-naïve participants within 5 …
Authors
PUNTHAKEE Z; HALL S; MCINNES N; SHERIFALI D; TSIPLOVA K; GHOSH M; HARRIS SB; LOCHNAN HA; RANSOM TPP; SIGAL RJ
Journal
Diabetes, Vol. 73, No. Supplement_1,
Publisher
American Diabetes Association
Publication Date
June 14, 2024
DOI
10.2337/db24-1870-lb
ISSN
0012-1797